ПЕРОРАЛЬНЫЕ МИОРЕЛАКСАНТЫ ПРИ НЕСПЕЦИФИЧЕСКОЙ БОЛИ В СПИНЕ

Скачать статью в PDF
Номер журнала: 
9
Год издания: 
2017

Н. Маслова (1), доктор медицинских наук, К. Агафонов (2) 1-Смоленский государственный медицинский университет 2-Смоленская областная клиническая больница E-mail: agafonova.marina.sm@mail.ru

Рассматриваются вопросы лечения неспецифической боли в спине с применением пероральных миорелаксантов.
Ключевые слова: 
неврология
лечение
неспецифическая боль в спине
баклофен
Для цитирования
Маслова Н., Агафонов К. ПЕРОРАЛЬНЫЕ МИОРЕЛАКСАНТЫ ПРИ НЕСПЕЦИФИЧЕСКОЙ БОЛИ В СПИНЕ . Врач, 2017; (9): 38-41

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

Список литературы: 
  1. Davies C., Nitz A., Mattacola C. et al. Practice patterns when treating patients with low back pain: a survey of physical therapists // Physiother. Theor. Pract. – 2014; 30 (6): 399–408.
  2. Hoy D., March L., Brooks P. et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study // Ann. Rheum. Dis. – 2014; 73: 968–74.
  3. Itz C., Ramaekers B., van Kleef M., et al. Medical specialists care and hospital costs for low back pain in the Netherlands // Eur. J. Pain. – 2016; 71 (4): 705–15.
  4. Le T., Montejano L., Cao Z. et al. Health care costs in US patients with and without a diagnosis of osteoarthritis // J. Pain Research. – 2012; 5: 23–30.
  5. Deyo R., Weinstein J. Low Back Pain // N. Engl. J. Med. – 2001; 344 (5): 363–70.
  6. Bogduk N., McGuirk B. Medical management of acute at chronic low back pain / Amsterdam: Elsevier, 2002.
  7. Dugan S. The role of exercise in the prevention and management of acute low back pain // Clin. Occup. Environ. Med. – 2006; 5: 615–32.
  8. Van Tulder M., Becker A., Bekkering T. et al. European guidelines for the management of acute nonspecific low back pain in primary care // Eur. Spine J. – 2006; 15 (2): 169–91.
  9. Liu P., Guo W., Zhao X. et al. Intrathecal baclofen, a GABAB receptor agonist, inhibits the expression of p-CREB and NR2B in the spinal dorsal horn in rats with diabetic neuropathic pain // Can. J. Physiol. Pharmacol. – 2014; 92 (8): 655–60.
  10. Huang D., Huang S., Peers C. et al. GABAB receptors inhibit low-voltage activated and high-voltage activated Ca(2+) channels in sensory neurons via distinct mechanisms // Biochem. Biophys. Res. Commun. – 2015; 465 (2): 188–93.
  11. Narendran R., Duarte R., Valyi A. et al. The need for and provision of intrathecal baclofen therapy for the management of spasticity in England: an assessment of the Hospital Episode Statistics database // BMJ Open. – 2015; 5 (6): e007517.
  12. Zaringhalam J., Manaheji H., Rastqar A. et al. Reduction of chronic non-specific low back pain: A randomised controlled clinical trial on acupuncture and baclofen // Chin. Med. – 2010; 5: 15.
  13. Al-Quliti K. Update on neuropathic pain treatment for trigeminal neuralgia. The pharmacological and surgical options // Neurosciences (Riyadh). – 2015; 2: 107–14.
  14. Ringel R., Roy E. Glossopharyngeal neuralgia: successful treatment with baclofen // Ann. Neurol. – 1987; 21 (5): 514–5.